ArticleCancer biology & therapy2017

Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cells.

Dmytro Starenki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.